Navigation Links
BioHorizons Announces the Purchase of Implant Logic Systems
Date:4/15/2008

BIRMINGHAM, Ala., and CEDARHURST, N.Y., April 15 /PRNewswire/ -- BioHorizons, Inc. ("BioHorizons") announced today the completion of its purchase of Implant Logic Systems, Ltd. ("ILS"), first announced on January 30, 2008. Implant Logic Systems will operate as a subsidiary of BioHorizons. Steve Boggan, CEO of BioHorizons, commented, "We are excited to expand our product offering to include VIP Virtual Implant Placement planning software and CAD/CAM surgical guides. This acquisition is a key milestone for us as we move the field of implant dentistry into the digital age."

About Implant Logic Systems

Implant Logic Systems is leading the dental implant market with innovative, technologically advanced, surgical tools which significantly improve implant placement quality and accessibility for both doctors and patients. Implant Logic Systems operates in the fields of software technology and medical devices to create a revolutionary implant placement technique. This technique is intended to be less invasive to the patient, shorten recovery time, reduce surgery time by up to 75%, and provide a more accurate implant placement. Implant Logic Systems has experienced rapid growth over the past several years. Implant Logic Systems' computer guided system has proven itself in thousands of clinical surgeries.

http://www.implantlogic.com

About BioHorizons

BioHorizons, Inc. is positioned to become the leader in implant dentistry as the only company with a complete product offering, and it will soon become the first company in the industry to market and brand an integrated solution. The Company will leverage the digital technology experience at its dental laboratories to create a revolutionary business model in the industry, streamlining a highly fragmented process to create efficiency, cost savings, and superior patient outcomes. BioHorizons, Inc. is headquartered in Birmingham, Alabama, and has a total of 21 facilities worldwide. The senior management team includes Steve Boggan, CEO, Wallace Sholdice, President, and Todd Strong, Chief Operating Officer, with 35 years of combined dental experience. They have successfully led and integrated 4 transactions while at BioHorizons, which have increased headcount from 112 employees to more than 1,000. These managers are visionaries within the industry, and are executing on a strategy that is transforming implant dentistry.
http://www.biohorizons.com

For More Information:

Steve Boggan

President and CEO of BioHorizons

205.967.7880


'/>"/>
SOURCE BioHorizons, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioHorizons Announces Agreement to Purchase Implant Logic Systems
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):